Table 1.
Demographical and clinical data for the study population a
| All patients, n = 140 b | |
|---|---|
| Age, years | 43.1 (8.7) |
| Gender (male/female) | 31 (22%)/109 (78%) |
| Ethnic Nordic background | 138 (99%) |
| Height, cm | 169 (149–197) |
| Weight, kg | 120 (90–192) |
| BMI, kg/m2 | 41.6 (35–55) |
| Body fat, percentage of body weight | 46.8 (31–51) |
| Body fat mass, kg | 54.1 (39–81) |
| Smoking (never/former/current) | 55 (39%)/60 (43%)/25 (18%) |
| Previous or present co-morbidity | |
| Diabetes mellitus | 26 (19%) |
| Polycystic ovary syndrome | 7 (6.4%) |
| Hypertension | 46 (33%) |
| Angina pectoris | 1 (0.7%) |
| Myocardial infarction | 2 (1.4%) |
| Stroke | 3 (2.1%) |
| Fibromyalgia | 25 (18%) |
| Hypothyroidism | 18 (13%) |
| Hyperthyroidism | 1 (0.7%) |
| Gallstones | 21 (15%) |
| Irritable bowel syndrome (Rome III) | 35 (26%) |
| Chronic obstructive pulmonary disease | 3 (2.1%) |
| Asthma | 34 (24%) |
| Hay fever | 19 (14%) |
| Osteoporosis | 0 (0%) |
| Asked for help for psychological problems | 28 (20%) |
| Mental distress (HSCL-10 score > 1.85) | 34 (24%) |
aData are expressed as mean (SD), median (min-max) and n (%)
bAll data are based on n = 140 with the following exceptions: 1) Irritable bowel syndrome: n = 135. 2) Polycystic ovary syndrome; n = 109 (females only)